Health
Study Sees Survival Boost For BRCA1/2 Carriers Tested Before Breast Cancer Diagnosis – Precision Oncology News
The analysis suggested survival and other benefits for breast cancer patients with BRCA1/2 mutations who were aware of their germline risk before diagnosis.
NEW YORK Women carrying pathogenic germline BRCA1/2 variants who develop breast cancer appear to fare better if their germline risk variants were uncovered prior to their cancer diagnosis, even if they do not undergo preventative procedures such as risk-reduction surgery, according to new research from Israel.
-
Noosa News23 hours agoWhere, when and why? Everything you need to know about Sunday’s pro-Palestine protest march in Brisbane
-
General19 hours agoIndia to defend ‘red lines’ as fresh tariffs loom
-
General16 hours agoAlbanese government to freeze construction code until 2029, fast-track housing approvals
-
General21 hours agoCollingwood’s Sarah Rowe returned after just 16 days from collarbone surgery as Magpies beat GWS in AFLW